Prognosis and Course of COVID-19 Infection in Hospitalised Patients

Completed

• Conditions: SARS-CoV Infection; Covid19

• Registration Number: NCT04752085
• Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Brief Summary

The aim of the cohort prospective observational study is to define the major factors influencing the course of COVID-19 infections and its prognosis in hospitalised patients.

The investigators plan to include 300 patients hospitalised with COVID-19 infection.

The phone contacts with patients are due after 90 and 180 days after discharge.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-11-01
• Study First Submitted: 2021-02-09
• Study First Submitted QC: 2021-02-10
• Study First Posted: 2021-02-12
• Primary Completion: 2021-03-01
• Status Verified: 2023-01
• Study Completion: 2023-01-10
• Last Update Submitted: 2023-01-24
• Last Update Posted: 2023-01-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 345

Inclusion Criteria

• Hospitalisation with COVID-19

Exclusion Criteria

• History of hospitalisation with COVID-19 infection
• Discharge from the hospital before the end of the treatment course
• Transfer to another hospital

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Need in biological therapy or/and respiratory support	Up to 1 month	The primary endpoint is the need in biological therapy or/and respiratory support including noninvasive ventilation during hospital stay

Secondary Outcome Measures

Name	Time	Method
Number of days spent in hospital	Up to 1 month	The investigators plan to assess the overall length of hospitalisation due to COVID-19 infection as an outcome measure
All-cause death	180 days	To assess the all-cause death 180 days after discharge

Trial Locations

Locations (2)

University Hospital #4; 🇷🇺 Moscow, Russian Federation

University Hospital #1; 🇷🇺 Moscow, Russian Federation